# RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease

> **NCT05392894** · PHASE3 · RECRUITING · sponsor: **King's College Hospital NHS Trust** · enrollment: 120 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **PROCEDURE:** Haploidentical stem cell transplantation
- **OTHER:** Standard medical care

## Key facts

- **NCT ID:** NCT05392894
- **Lead sponsor:** King's College Hospital NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-23
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-05-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05392894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05392894, "RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05392894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*